Permanent J Code for OPDIVO Qvantig™ (nivolumab and hyaluronidase-nvhy)

OPDIVO Qvantig™

(nivolumab and hyaluronidase-nvhy)

Effective July 1, 2025: J9289

Injection, nivolumab, 2 mg and hyaluronidase-nvhy

CMS has granted a unique J-code, J9289, for the use of OPDIVO Qvantig™ across all outpatient settings. J9289 is effective for dates of service on or after July 1, 2025. Bristol Myers Squibb would appreciate your partnership in updating systems and locations involved with the HCPCS and NDC information for J9289.

HCPCS Coding Information:

HCPCS Code	J9289
HCPCS Descriptor	Injection, nivolumab, 2 mg and hyaluronidase-nvhy
HCPCS Units per Package	300 Units
11-Digit NDC Code	00003-6120-01*
Package Description	600 mg nivolumab and 10,000 units hyaluronidase per 5 mL (120 mg/2,000 units per mL) solution in a single-dose vial

*The red zero converts the 10-digit NDC to the 11-digit NDC. Payer requirements regarding the use of NDCs may vary. Electronic data exchange generally requires use of the 11-digit NDC.

For more information around billing and coding for OPDIVO Qvantig™, please vist the BMS Access Support® website at the link below.

Visit Here

Access Support and the BMS logo are registered trademarks of Bristol-Myers Squibb Company. 1992-US-2500104. 6/2025